Report Detail
Global and United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026
- RnM4197967 |
- 09 September, 2020 |
- Global |
- 94 Pages |
- QYResearch |
- Other
Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Scope and Market Size
B-Cell Maturation Antigen(BCMA) Targeted Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Bispecific Antibodies
Antibody Drug Conjugates
Chimeric Antigen Receptor T-Cells
Market segment by Application, split into
Liver Cancer
Respiratory Cancer
Brain Cancer
Others
Based on regional and country-level analysis, the B-Cell Maturation Antigen(BCMA) Targeted Therapies market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Transposagen Biopharmaceuticals
Sutro Biopharma
Malin Corporation
Eureka Therapeutics
firstVentury Equity
Five Prime Therapeutics
Credit Suisse Securities
Dana-Farber Cancer Institute
Deerfield Partners
Onyx Pharmaceuticals
Juno Therapeutics
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Bispecific Antibodies
- 1.2.3 Antibody Drug Conjugates
- 1.2.4 Chimeric Antigen Receptor T-Cells
- 1.3 Market by Application
- 1.3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application: 2020 VS 2026
- 1.3.2 Liver Cancer
- 1.3.3 Respiratory Cancer
- 1.3.4 Brain Cancer
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Perspective (2015-2026)
- 2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Trends by Regions
- 2.2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Share by Regions (2015-2020)
- 2.2.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Market Size
- 3.1.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Revenue (2015-2020)
- 3.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Players (2015-2020)
- 3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
- 3.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio
- 3.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue in 2019
- 3.5 Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Area Served
- 3.6 Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Solution and Service
- 3.7 Date of Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Breakdown Data by Type (2015-2026)
- 4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Type (2015-2020)
- 4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Type (2021-2026)
5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Breakdown Data by Application (2015-2026)
- 5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Application (2015-2020)
- 5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)
- 6.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
- 6.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)
- 6.4 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)
- 7.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
- 7.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)
- 7.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)
- 8.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
- 8.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)
- 8.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)
- 9.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
- 9.3 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)
- 9.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)
- 10.2 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
- 10.3 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)
- 10.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Transposagen Biopharmaceuticals
- 11.1.1 Transposagen Biopharmaceuticals Company Details
- 11.1.2 Transposagen Biopharmaceuticals Business Overview
- 11.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.1.4 Transposagen Biopharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020))
- 11.1.5 Transposagen Biopharmaceuticals Recent Development
- 11.2 Sutro Biopharma
- 11.2.1 Sutro Biopharma Company Details
- 11.2.2 Sutro Biopharma Business Overview
- 11.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.2.4 Sutro Biopharma Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 11.2.5 Sutro Biopharma Recent Development
- 11.3 Malin Corporation
- 11.3.1 Malin Corporation Company Details
- 11.3.2 Malin Corporation Business Overview
- 11.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.3.4 Malin Corporation Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 11.3.5 Malin Corporation Recent Development
- 11.4 Eureka Therapeutics
- 11.4.1 Eureka Therapeutics Company Details
- 11.4.2 Eureka Therapeutics Business Overview
- 11.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.4.4 Eureka Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 11.4.5 Eureka Therapeutics Recent Development
- 11.5 firstVentury Equity
- 11.5.1 firstVentury Equity Company Details
- 11.5.2 firstVentury Equity Business Overview
- 11.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.5.4 firstVentury Equity Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 11.5.5 firstVentury Equity Recent Development
- 11.6 Five Prime Therapeutics
- 11.6.1 Five Prime Therapeutics Company Details
- 11.6.2 Five Prime Therapeutics Business Overview
- 11.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.6.4 Five Prime Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 11.6.5 Five Prime Therapeutics Recent Development
- 11.7 Credit Suisse Securities
- 11.7.1 Credit Suisse Securities Company Details
- 11.7.2 Credit Suisse Securities Business Overview
- 11.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.7.4 Credit Suisse Securities Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 11.7.5 Credit Suisse Securities Recent Development
- 11.8 Dana-Farber Cancer Institute
- 11.8.1 Dana-Farber Cancer Institute Company Details
- 11.8.2 Dana-Farber Cancer Institute Business Overview
- 11.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.8.4 Dana-Farber Cancer Institute Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 11.8.5 Dana-Farber Cancer Institute Recent Development
- 11.9 Deerfield Partners
- 11.9.1 Deerfield Partners Company Details
- 11.9.2 Deerfield Partners Business Overview
- 11.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.9.4 Deerfield Partners Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 11.9.5 Deerfield Partners Recent Development
- 11.10 Onyx Pharmaceuticals
- 11.10.1 Onyx Pharmaceuticals Company Details
- 11.10.2 Onyx Pharmaceuticals Business Overview
- 11.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 11.10.4 Onyx Pharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 11.10.5 Onyx Pharmaceuticals Recent Development
- 11.11 Juno Therapeutics
- 10.11.1 Juno Therapeutics Company Details
- 10.11.2 Juno Therapeutics Business Overview
- 10.11.3 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
- 10.11.4 Juno Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
- 10.11.5 Juno Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on B-Cell Maturation Antigen(BCMA) Targeted Therapies. Industry analysis & Market Report on B-Cell Maturation Antigen(BCMA) Targeted Therapies is a syndicated market report, published as Global and United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
